We are a scientific leader in dermatologic solutions that recently announced a strategic pivot from pharmaceutical development to begin focusing on the development and commercialization of direct-to-consumer skincare solutions. The Company is currently developing a first-of-its-kind skin renewal and OTC acne treatment that incorporates our Bioneedle. We plan to launch our first cosmetic product, called the Foundational Treatment, for a once weekly skin renewal under our Tome skincare brand in the middle of 2026 with the launch of our OTC acne Clearing Treatment to follow shortly thereafter. Visit tomeskincare.com to find more information on our Tome skincare products.